Ever wondered which Dr Reddy’s manufacturing plant in India truly stands out from the rest? With so many factories producing vital medications, choosing the best one can feel overwhelming. Finding a top-notch manufacturer isn’t just about quality—it means better reliability, cutting-edge technology, and peace of mind. Imagine partnering with a plant that consistently delivers excellence, ensuring you meet every standard and deadline. Ready to discover which Dr Reddy’s facilities lead the pack? Dive in and make an informed choice!
Dr Reddy’s gets 2 observations from USFDA for Telangana API plant
Product Details:
Active pharmaceutical ingredients (APIs) produced at Dr. Reddy’s Telangana facility.
Pros:
– APIs are manufactured by a prominent pharmaceutical company with global
– Facility inspected and reviewed by the US FDA, showing engagement with
Cons:
– Received two observations from the US FDA, indicating areas of regulatory
– Observations may delay approvals or impact credibility until addressed.
Global Locations – Dr. Reddy’s Laboratories
Where Are Dr Reddy’s Drugs Manufactured? Inside India’s Pharma Powerhouse
Product Details:
Dr Reddy’s manufactures a wide lineup of pharmaceutical products including generic tablets, capsules, injections, creams, ointments, and advanced oncology drugs. Production spans formulations (oral solids and liquids), APIs (Active Pharmaceutical Ingredients), biologics, and injectables, with over 500 products marketed to more than 60 countries.
Technical Parameters:
– Facilities produce tablets, capsules, syrups, injectables, creams, and oncology
– Manufacturing plants cover areas between 40 and 100+ acres; up to 2,000
– Advanced technologies: robotic arms, electronic batch records, automated
– Certified by US FDA, WHO, European Medicines Agency, and have ISO-certified
Application Scenarios:
– Prescription and over-the-counter medicines supplied to pharmacies and
– Supply of oncology injectables and high-value drugs for specialized hospital
– APIs exported for pharmaceutical manufacturing across 66 countries including
– Generic medications distributed through healthcare channels worldwide
Pros:
– Extensive manufacturing scale and export capability (500+ products, 66
– Stringent quality control with international certifications (US FDA, WHO, EMA,
– Advanced manufacturing technologies boost efficiency, safety, and consistency
– Diverse product portfolio covering both basic and specialized medicines
Cons:
– Majority of manufacturing is centralized in India, which may lead to logistical
– Reliance on regulatory compliance for global exports adds risk of disruption if
Dr Reddy’s Laboratories: Dr Reddy’s Faces USFDA Scrutiny with 2 …
Product Details:
Dr. Reddy’s Laboratories operates an Active Pharmaceutical Ingredient (API) manufacturing plant in Telangana, India, which supplies pharmaceutical ingredients for drug production. The plant has recently been subject to scrutiny by the USFDA (United States Food and Drug Administration), resulting in two observations following an inspection.
Technical Parameters:
– API manufacturing facility located in Telangana, India
– Subject to USFDA cGMP (current Good Manufacturing Practice) compliance standards
– Manufactures active pharmaceutical ingredients for global pharmaceutical supply
Application Scenarios:
– Supply of APIs for formulation of finished pharmaceutical products
– Export of pharmaceutical ingredients to regulated markets like the United States
– Production of generic drugs and intermediates for global distribution
Pros:
– Global regulatory scrutiny indicates potential for high compliance and
– Contributes to the supply chain for essential medicines and generics
Cons:
– Recent USFDA inspection resulted in two observations, possibly signaling
– Potential delays or additional costs may arise if remediation measures are
Dr Reddys Labs’ manufacturing facility gets two form 483 observations …
Dr. Reddy’s Laboratories – Good Health Can’t Wait
Product Details:
Dr. Reddy’s Laboratories is a global pharmaceutical company involved in the research, development, and manufacturing of active pharmaceutical ingredients (APIs) and finished dosage forms (formulations). The company has multiple manufacturing and R&D locations primarily in India and operates worldwide.
Technical Parameters:
– Multiple API plants with specific locations in Telangana and Andhra Pradesh,
– Manufacturing units identified as API Hyderabad Plant 1, Plant 2, Plant 3, API
– Facility infrastructure includes industrial estate plots and Special Economic
– Corporate office located in Hyderabad, Telangana, India
Application Scenarios:
– Pharmaceutical manufacturing and supply of active pharmaceutical ingredients to
– Contract manufacturing and research collaborations with international business
– Supplying APIs and finished formulations to hospitals, clinics, and pharmacies
– Engagement in R&D activities for development of new drugs and healthcare
Pros:
– Global presence with corporate and manufacturing locations in multiple countries
– Diverse manufacturing facilities for both API and formulations
– Strong focus on research and development capabilities
Cons:
– Limited public technical product details available on the referenced page
– No direct mention of specific pharmaceuticals or finished dosage forms
FDA slams Dr. Reddy’s plants in India with a pair of Form 483s
Product Details:
Dr. Reddy’s Laboratories manufactures generic pharmaceutical products at their Indian production plants.
Application Scenarios:
– Pharmaceutical manufacturing
– Supplying generic medicines to global markets
Pros:
– Provides affordable generic medicines
– Operates multiple manufacturing facilities for large-scale production
Cons:
– Received FDA Form 483s highlighting quality and compliance issues
– Identified problems with cleanliness, record-keeping, and production processes
U.S. FDA issues two observations to Dr. Reddy’s API plant in Telangana
Product Details:
Active Pharmaceutical Ingredients (APIs) produced at Dr. Reddy’s plant in Telangana.
Application Scenarios:
– Pharmaceutical manufacturing
– Supplying raw materials for drug production
Pros:
– Regulated and inspected by the U.S. FDA
– Part of a reputable pharmaceutical company
Cons:
– Recent FDA inspection resulted in two observations indicating compliance issues
USFDA issues seven observations to Dr Reddy’s Hyderabad manufacturing plant
Cons:
– US FDA issued seven observations to the Hyderabad manufacturing plant,
– Potential impact on manufacturing operations or product approvals due to
USFDA Inspection Results in Observations for Dr Reddy’s API Plant
Product Details:
Active Pharmaceutical Ingredients (APIs) manufactured by Dr. Reddy’s Laboratories at their Pydibhimavaram facility in Srikakulam, Andhra Pradesh, India.
Technical Parameters:
– Manufactured at API plant located in Pydibhimavaram, Srikakulam, Andhra Pradesh
– Subject to inspection and regulatory compliance by the US Food and Drug
Application Scenarios:
– Used as raw materials for pharmaceutical formulations.
– Intended for export and use in regulated markets including the United States.
Pros:
– Products inspected and regulated by international authorities, ensuring quality
Cons:
– Recent USFDA inspection resulted in observations, suggesting compliance or
Comparison Table
Company | Product Details | Pros | Cons | Website |
---|---|---|---|---|
Dr Reddy’s gets 2 observations from USFDA for Telangana API plant | Active pharmaceutical ingredients (APIs) produced at Dr. Reddy’s Telangana | APIs are manufactured by a prominent pharmaceutical company with global | Received two observations from the US FDA, indicating areas of regulatory | economictimes.indiatimes.com |
Global Locations – Dr. Reddy’s Laboratories | www.drreddys.com | |||
Where Are Dr Reddy’s Drugs Manufactured? Inside India’s Pharma Powerhouse | Dr Reddy’s manufactures a wide lineup of pharmaceutical products including | Extensive manufacturing scale and export capability (500+ products, 66 | Majority of manufacturing is centralized in India, which may lead to logistical | risecorp.co.in |
Dr Reddy’s Laboratories: Dr Reddy’s Faces USFDA Scrutiny with 2 … | Dr. Reddy’s Laboratories operates an Active Pharmaceutical Ingredient (API) | Global regulatory scrutiny indicates potential for high compliance and | Recent USFDA inspection resulted in two observations, possibly signaling | pharma.economictimes.indiatimes.com |
Dr Reddys Labs’ manufacturing facility gets two form 483 observations … | www.business-standard.com | |||
Dr. Reddy’s Laboratories – Good Health Can’t Wait | Dr. Reddy’s Laboratories is a global pharmaceutical company involved in the | Global presence with corporate and manufacturing locations in multiple | Limited public technical product details available on the referenced page No | www.drreddys.com |
FDA slams Dr. Reddy’s plants in India with a pair of Form 483s | Dr. Reddy’s Laboratories manufactures generic pharmaceutical products at their | Provides affordable generic medicines Operates multiple manufacturing | Received FDA Form 483s highlighting quality and compliance issues Identified | www.fiercepharma.com |
U.S. FDA issues two observations to Dr. Reddy’s API plant in Telangana | Active Pharmaceutical Ingredients (APIs) produced at Dr. Reddy’s plant in | Regulated and inspected by the U.S. FDA Part of a reputable pharmaceutical | Recent FDA inspection resulted in two observations indicating compliance issues | www.thehindu.com |
USFDA issues seven observations to Dr Reddy’s Hyderabad manufacturing plant | US FDA issued seven observations to the Hyderabad manufacturing plant, | www.business-standard.com | ||
USFDA Inspection Results in Observations for Dr Reddy’s API Plant | Active Pharmaceutical Ingredients (APIs) manufactured by Dr. Reddy’s | Products inspected and regulated by international authorities, ensuring quality | Recent USFDA inspection resulted in observations, suggesting compliance or | www.devdiscourse.com |
Frequently Asked Questions (FAQs)
How can I find Dr. Reddy’s manufacturing plants in India?
You can find details about Dr. Reddy’s manufacturing plants by visiting the official Dr. Reddy’s website, which lists their facility locations. Business directories, pharmaceutical trade associations, or professional networking platforms like LinkedIn can also be helpful.
What factors should I consider when choosing a Dr. Reddy’s manufacturing plant as my supplier?
Consider the plant’s certifications (like WHO-GMP or US FDA approval), production capacity, product range, location, and reputation for quality. It’s also important to assess their reliability and ability to meet your volume and timeline needs.
How do I verify the quality standards of a Dr. Reddy’s manufacturing plant?
You can request copies of quality certifications, audit reports, and compliance records. International approvals (e.g., US FDA, EU GMP) are a good sign. If possible, arrange for a site visit or third-party audit to confirm their quality systems.
Can I directly contact Dr. Reddy’s for supply and partnership inquiries?
Yes, Dr. Reddy’s has dedicated business inquiry portals on their website where you can submit your details. Alternatively, you can reach out via their corporate email or telephone numbers listed online to initiate discussions.
Is it possible to request a sample or visit the plant before making a decision?
Many manufacturers, including Dr. Reddy’s, allow potential clients to request samples or schedule site visits, especially for large or ongoing supply agreements. Contact their sales or business development team to arrange this.